Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05844397 · ClinicalTrials.gov registry record · NA
SMILE vs. LASIK Using Contoura With Phorcides
A NA study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT05844397 is a NA study that has completed, run by 59th Medical Wing. The registered enrollment target is 56 participants.
The verdict
NCT05844397, a NA study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
Subjects will undergo SMILE surgery in one eye and LASIK using Contoura with Phorcides on the contralateral eye to correct myopia.
Interventions
- DEVICE WaveLight EX500 Excimer Laser System
- DEVICE VisuMax Surgical Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2024-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05844397
The ClinicalTrials.gov registry entry for NCT05844397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WaveLight EX500 Excimer Laser System is the first listed.
NCT05844397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05844397 about?
NCT05844397 is a clinical study titled "SMILE vs. LASIK Using Contoura With Phorcides". Subjects will undergo SMILE surgery in one eye and LASIK using Contoura with Phorcides on the contralateral eye to correct myopia.
What is the current status of trial NCT05844397?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2023-05-09. Estimated completion is 2024-05-14.
What interventions are being tested in trial NCT05844397?
The interventions under investigation include: WaveLight EX500 Excimer Laser System (DEVICE), VisuMax Surgical Laser (DEVICE).
Who is sponsoring clinical trial NCT05844397?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.